Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2430-2018Class II

Apollo XT Suture Anchor, 5.5 x 15

Valeris Medical / initiated 2018-01-22 / Terminated / root cause: manufacturing process

Valeris Medical, LLC began a recall of Apollo XT Suture Anchor, 5.5 x 15 Product Usage: Apollo XT Suture Anchors are intended for: Shoulder - Rotator Cuff Repair - Bankart Repair - SLAP Lesion... on . FDA classified it as Class II and gives the reason as "The label on Apollo XT 5.5mm Suture Anchor (part # XTS-5515; lots 2358, 2362, and 2363) indicated that the anchor screw material was titanium, however that part number is made of PEEK". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2430-2018
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Valeris Medical
Product
Apollo XT Suture Anchor, 5.5 x 15 Product Usage: Apollo XT Suture Anchors are intended for: Shoulder - Rotator Cuff Repair - Bankart Repair - SLAP Lesion Repair - Biceps Tenodesis - Acromio-Clavicular Separation Repair - Deltoid Repair - Capisular Shift or Capsulolabral Reconstruction Foot/Ankle - Lateral Stabilization - Medial Stabilization - Achilles Tendon Repair Knee - Medial Collateral Ligament Repair - Lateral Collateral Ligament Repair - Posterior Oblique Ligament Repair - Illiotibial Band Tenodesis Elbow - Biceps Tendon Reattachment - Ulnar or Radial Collateral Ligament Reconstruction Hip - Capsular Repair - Acetabular Labral Repair
Product code
MBI Fastener, Fixation, Nondegradable, Soft Tissue
Reason for recall
The label on Apollo XT 5.5mm Suture Anchor (part # XTS-5515; lots 2358, 2362, and 2363) indicated that the anchor screw material was titanium, however that part number is made of PEEK.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
Valeris Medical notified customers on approximately 01/20/2018 via phone call, text, or email. A formal letter was mailed to customers on 02/09/2018. The letter identified the affected product, problem and actions to be taken. Customers were instructed to remove affected products from inventory to quarantine, affix replacement labels provided by Valeris over the current labeling, and notify any customers if product was further distributed to so the product can be quarantined and returned for labeling. Additionally, Valeris requested confirmation in writing that the field correction action has been completed.
Quantity in commerce
113 units
Distribution
US Nationwide Distribution in the states of California and Oklahoma.
Product codes and lots
Model No. XT-5515, Lot No. 2358, 2362, 2363

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2430-2018
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2430-2018Class IITerminatedVoluntary: Firm initiated